由两种在日常实践中处方的常见药物的组合引起的高氨酸酸
A Duncan1,2, H McDermott1,2, S Corcoran1,2
1Department of Medicine, Bon Secours Hospital, Dublin, Ireland.
Oxford medical case reports
|June 1, 2023
概括
一种罕见的药物相互作用可能导致pyroglutamic代谢酸性化. 在患有传染性内心炎的患者中,高剂量的克西林和青需要对这种并发症进行仔细监测.
科学领域:
- 内部医学 内部医学
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
背景情况:
- 传染性内心炎是一种严重的感染,需要立即接受抗生素治疗.
- 甲和甲是用于治疗各种疾病的常用药物.
- 代谢性酸症是一种严重的疾病,其特点是身体的酸水平失衡.
研究的目的:
- 报告一种罕见的pyroglutamic代谢酸性化病例.
- 为了突出克洛西林和 acetamol之间潜在的药物相互作用.
- 强调认识到这种不良事件的重要性.
主要方法:
- 一个71岁的女性患者的案例介绍.
- 对临床过程和实验室发现的审查,包括血液气体分析.
- 诊断pyroglutamic代谢酸性化症的情况.
主要成果:
- 患者出现了升高的阴离子间隙代谢酸症.
- 被诊断为一个并发症的pyroglutamic代谢酸症.
- 这种情况归因于高剂量克西林和 acetamol之间罕见的相互作用.
结论:
- 高剂量的克洛西林和青很少会相互作用,导致皮洛胺代谢酸症.
- 这种代谢并发症是一个重要的,尽管很少见的不良药物事件.
- 临床警是必要的,以识别和管理这种情况.
相关概念视频
Inborn Errors of Metabolism
207
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
207
Combined Effects of Drugs: Synergism
4.1K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.1K
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
304
Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme...
304
Anticholinesterase Agents: Poisoning and Treatment
928
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
928
Phase II Reactions: Acetylation Reactions
280
Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
280
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
272
Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
272


